MENU
RLAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Relay Therapeutics (RLAY) Ownership - Who owns Relay Therapeutics?
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients... Show more
Profile
Industry
N/A
Address
399 Binney Street
Phone
+1 617 370-8837
Employees
323
Web
https://www.relaytx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
389.05M
P/E Ratio
N/A
Total Cash
781.32M
Projected Growth
N/A
Total Debt
48.5M
Revenue
10.01M
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash/Share
4.61
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price
Fundamentals
RLAY
Capitalization
389M
P/E Ratio
N/A
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash
781M
Total Cash/Share
4.61
Total Debt
48.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
10M
ROE
N/A
Book Value
778M
P/B Ratio
0.50
Cash Flow
N/A
Earnings
-2.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
168K
Current Ratio
15.95
Current Revenue Per Employee
32385.11
Dividends Per Share - Security
N/A
EBITDA
-380.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.38
Shares Held By Institutions
964M
Shares Outstanding - Current
170M
Total Liabilities
93.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.417
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
399 Binney Street
Phone
+1 617 370-8837
Employees
323
Web
https://www.relaytx.com